Interleukin-8 Promoter Polymorphism −251 A/T and Treatment Response in Neovascular Age-related Macular Degeneration

References

• Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–e116. doi:10.1016/S2214-109X(13)70145-1
   PubMed Web of Science ®Google Scholar
• Morris B, Imrie F, Armbrecht AM, Dhillon B. Age-related macular degeneration and recent developments: new hope for old eyes? Postgrad Med J. 2007;83(979):301–307. doi:10.1136/pgmj.2006.052944
   PubMed Web of Science ®Google Scholar
• Martin DF. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration. N Engl J Med. 2011;364(20):1897–1908. doi:10.1056/NEJMoa1102673
   PubMed Web of Science ®Google Scholar
• Bloch SB, Larsen M, Munch IC. Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153(2):209–213.e2. doi:10.1016/j.ajo.2011.10.016
   PubMed Web of Science ®Google Scholar
• Gillies MC, Campain A, Barthelmes D, et al. Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration. Ophthalmology. 2015;122(9):1837–1845. doi:10.1016/j.ophtha.2015.05.010
   PubMed Web of Science ®Google Scholar
• Rozing MP, Durhuus JA, Krogh Nielsen M, et al. Age-related macular degeneration: a two-level model hypothesis. Prog Retin Eye Res. 2020;76:100825. doi:10.1016/j.preteyeres.2019.100825
   PubMed Web of Science ®Google Scholar
• Subhi Y, Krogh Nielsen M, Molbech CR, et al. Plasma markers of chronic low-grade inflammation in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Acta Ophthalmol (Copenh). 2019;97(1):99–106. doi:10.1111/aos.13886
   PubMed Web of Science ®Google Scholar
• Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA. 2004;291(6):704–710. doi:10.1001/jama.291.6.704
   PubMed Web of Science ®Google Scholar
• Falk MK, Singh A, Faber C, Nissen MH, Hviid T, Sørensen TL. CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD. PLoS One. 2014;9(12):e112473. doi:10.1371/journal.pone.0112473
   PubMed Web of Science ®Google Scholar
• Subhi Y, Krogh Nielsen M, Molbech CR, et al. CD11b and CD200 on Circulating Monocytes Differentiate Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy. Invest Opthalmol Vis Sci. 2017;58(12):5242. doi:10.1167/iovs.17-22479
   PubMed Web of Science ®Google Scholar
• Waugh DJJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res off J Am Assoc Cancer Res. 2008;14(21):6735–6741. doi:10.1158/1078-0432.CCR-07-4843
   PubMed Web of Science ®Google Scholar
• Hautamäki A, Kivioja J, Vavuli S, et al. INTERLEUKIN 8 PROMOTER POLYMORPHISM PREDICTS THE INITIAL RESPONSE TO BEVACIZUMAB TREATMENT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION. Retina. 2013;33(9):1815–1827. doi:10.1097/IAE.0b013e318285cf92
   PubMed Web of Science ®Google Scholar
• Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2005;14(11 Pt 1):2487–2493. doi:10.1158/1055-9965.EPI-05-0326
   Google Scholar
• Hildebrand F, Stuhrmann M, van Griensven M, et al. Association of IL-8-251A/T polymorphism with incidence of Acute Respiratory Distress Syndrome (ARDS) and IL-8 synthesis after multiple trauma. Cytokine. 2007;37(3):192–199. doi:10.1016/j.cyto.2007.03.008
   PubMed Web of Science ®Google Scholar
• Goverdhan SV, Ennis S, Hannan SR, et al. Interleukin-8 promoter polymorphism −251A/T is a risk factor for age-related macular degeneration. Br J Ophthalmol. 2008;92(4):537–540. doi:10.1136/bjo.2007.123190
   PubMed Web of Science ®Google Scholar
• Tsai YY, Lin JM, Wan L, et al. Interleukin Gene Polymorphisms in Age-Related Macular Degeneration. Invest Opthalmol Vis Sci. 2008;49(2):693. doi:10.1167/iovs.07-0125
   PubMed Web of Science ®Google Scholar
• Hautamäki A, Seitsonen S, Holopainen JM, et al. The genetic variant rs4073 A→T of the Interleukin‐8 promoter region is associated with the earlier onset of exudative age‐related macular degeneration. Acta Ophthalmol (Copenh). 2015;93(8):726–733. doi:10.1111/aos.12799
   Web of Science ®Google Scholar
• Lazzeri S, Orlandi P, Piaggi P, et al. IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration. Pharmacogenomics. 2016;17(1):35–39. doi:10.2217/pgs.15.153
   PubMed Web of Science ®Google Scholar
• Kaiser PK. Prospective evaluation of visual acuity assessment: a comparison of Snellen versus ETDRS charts in clinical practice (An AOS Thesis). Trans Am Ophthalmol Soc. 2009;107:311–324.
   PubMedGoogle Scholar
• Amoaku WM, Chakravarthy U, Gale R, et al. Defining response to anti-VEGF therapies in neovascular AMD. Eye. 2015;29(6):721–731. doi:10.1038/eye.2015.48
   PubMed Web of Science ®Google Scholar
• Ristl R. Sample Size Calculator at the University of Vienna. Available from: https://homepage.univie.ac.at/robin.ristl/samplesize.php;. Accessed July 7, 2023.
   Google Scholar
• Krogh Nielsen M, Subhi Y, Molbech CR, Falk MK, Nissen MH, Sørensen TL. Systemic Levels of Interleukin-6 Correlate With Progression Rate of Geographic Atrophy Secondary to Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2019;60(1):202–208. doi:10.1167/iovs.18-25878
   PubMed Web of Science ®Google Scholar
• Krogh Nielsen M, Subhi Y, Molbech CR, Falk MK, Nissen MH, Sørensen TL. Chemokine Profile and the Alterations in CCR5-CCL5 Axis in Geographic Atrophy Secondary to Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2020;61(4):28. doi:10.1167/iovs.61.4.28
   PubMed Web of Science ®Google Scholar
• Andia DC, de Oliveira NFP, Letra AM, Nociti FH, Line SRP, de Souza AP. Interleukin-8 gene promoter polymorphism (rs4073) may contribute to chronic periodontitis. J Periodontol. 2011;82(6):893–899. doi:10.1902/jop.2010.100513
   PubMed Web of Science ®Google Scholar
• Ricci F, Staurenghi G, Lepre T, et al. Haplotypes in IL-8 Gene Are Associated to Age-Related Macular Degeneration: a Case-Control Study. PLoS One. 2013;8(6):e66978. doi:10.1371/journal.pone.0066978
   PubMed Web of Science ®Google Scholar
• Steinbrugger I, Haas A, Maier R, et al. Analysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion. Mol Vis. 2009;15:609–618.
   PubMed Web of Science ®Google Scholar
• Maier R, Steinbrugger I, Haas A, et al. Role of inflammation-related gene polymorphisms in patients with central retinal vein occlusion. Ophthalmology. 2011;118(6):1125–1129. doi:10.1016/j.ophtha.2010.10.014
   PubMed Web of Science ®Google Scholar
• Dong L, Bai J, Jiang X, et al. The gene polymorphisms of IL-8(−251T/A) and IP-10(−1596C/T) are associated with susceptibility and progression of type 2 diabetic retinopathy in northern Chinese population. Eye Lond Engl. 2017;31(4):601–607. doi:10.1038/eye.2016.287
   PubMed Web of Science ®Google Scholar
• Bek T, Klug SE. Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration. Clin Ophthalmol Auckl NZ. 2018;12:473–479. doi:10.2147/OPTH.S158760
   PubMed Web of Science ®Google Scholar
• Bjerregaard T, Krogh Nielsen M, Molbech CR, Subhi Y, Sørensen TL. Treatment failure in neovascular age-related macular degeneration is associated with a complex chemokine receptor profile. BMJ Open Ophthalmol. 2019;4(1):e000307. doi:10.1136/bmjophth-2019-000307
   PubMed Web of Science ®Google Scholar